Table 2 Proteins related to clinical characteristics among suicide completers.

From: Proteomic profiling of postmortem prefrontal cortex tissue of suicide completers

Comparative groups

Psychiatric disorders

Medications

Alcohol intake

Psychiatric disorder vs. No disorder (11: 12)

Schizophrenia vs. No disorder (7: 12)

MDD vs. No disorder (4: 12)

Psychotropics vs. No medication (10: 13)

Antipsychotics vs. No medication (6: 13)

Alcohol intake vs. No-alcohol (6: 17)

Number of DEPs (Student’s t-test P < 0.05 & FC > 1.2)

4

13

8

5

12

34

Gene names

NIPSNAP3B

EPB41L1

FGG

BCAS1

CEP170B

GFAP

 

GSTT1a

NIPSNAP3B

NIPSNAP3B

NIPSNAP3B

EPB41L1

CACNA1E

 

TSPAN8

CHI3L1

ACBD3

NQO1

EPB41L1

SLC1A3

 

NQO1

STBD1

DCHS1

GPNMB

BCAS1

COL6A1

  

EMILIN2

GSTT2

APOA2

CFAP36

ANK3

  

SLC14A1

LRP2

 

COL4A1a

RASA4

  

MORF4L2

ABCC10

 

CD82a

COL6A3

  

NELFE

CHRNA4

 

STBD1

RPS4Y1a

  

TSPAN8

  

MORF4L2

SLC7A11

  

CDKN2AIP

  

NELFE

CD44

  

NQO1

  

TTR

MICALL2

  

ABRACLa

  

GPNMB

FAM92A1

  

UBE2D3a

   

S100A10a

      

TSPAN15

      

MRGPRFa

      

MAN2A1

      

IGHG1

      

IGHG1

      

SERPINA1

      

IGHA1

      

IGKV3-11

      

IGHM

      

HPX

      

IGLC2

      

IGLL5

      

IGHM

      

IGKV3-20

      

AHSG

      

IGKV2D-28

      

IGKV1D-33

      

IGKV2-30

      

IGLV3-21

      

SYT6

      

CD5L

  1. DEP differentially expressed protein, MDD major depressive disorder.
  2. aProteins common to suicide vs. normal analyses.